Latest News

  • Study Links Executive Functioning to Physical Activity in Older Adults

    Diagnostics World | Researchers in Belgium compared cognition to movement data in healthy adults looking for links that might predict cognitive decline later in life. The study is part of the PASOCA-project (how Physical Activity and Sleep relate to Optimal Cognitive Ageing), a two-year longitudinal, observational study examining 24-hour movement behaviors and cognitive function in cognitively healthy adults aged 55 and older residing in Flanders, Belgium.

    Apr 14, 2026

  • Using Genomics to Tease Apart Racial Disparities in Breast Cancer Outcomes

    Diagnostics World | New research released in pre-print from npj Breast Cancer digs deeper into the racial disparities of breast cancer and how the MammaPrint and BluePrint genomic tests from Agendia handle the differences.

    Apr 10, 2026

  • Using Genomics to Tease Apart Racial Disparities in Breast Cancer Outcomes

    Diagnostics World | New research released in pre-print from npj Breast Cancer digs deeper into the racial disparities of breast cancer and how the MammaPrint and BluePrint genomic tests from Agendia handle the differences.

    Apr 10, 2026

  • From Fingertip to Mainstream: Babson Diagnostics Bets Its Decade of Science Is Ready for Prime Time

    Diagnostics World | When Web Golinkin joined Babson Diagnostics as an advisor in mid-2024, he did what experienced healthcare executives do: he listened, watched, and formed a thesis. After eight months advising, a brief stint as president and chief commercial officer, and now one month into the CEO role, his thesis has hardened into conviction.

    Apr 9, 2026

  • The Future of Blood Testing Lies in Understanding the Whole Body

    Diagnostics World | For decades, blood testing innovation has focused on improving patient testing for earlier and faster intervention. Advances in sequencing, automation, and molecular testing have dramatically improved our ability to biologically monitor patients. But as powerful as these technologies have become, they often still operate within a limited framework: they look for a biomarker panel that constitutes a single signal tied to a single disease.

    Apr 3, 2026

  • Handheld AI-Powered Eye Scanner Could Reach More Patients

    Diagnostics World | Research out of Tohoku University in Sendai, Japan, provides a model for easily assessing front of the eye health outside of hospitals. The research team envisions employing the portable AI-powered scanning slit-light device in remote eye-screening camps, elderly-care facilities, pharmacies, or even train stations to make ophthalmic care more accessible, so patients can be assessed any place and any time.

    Apr 2, 2026

  • Roche ApoE4 Blood Test

    Diagnostics World | Roche has received CE Mark approval for its Elecsys Apolipoprotein E4 biomarker test – the first in-vitro diagnostic (IVD) immunoassay to identify the presence of the ApoE4 gene variant in the bloodstream.

    Apr 1, 2026

  • Follow the Money: Precision Genetic Drugs, Engineering Synthetic Macrocyclic Peptides, More

    Diagnostics World | BreezeBio, formerly known as GenEdit, advances their NanoGalaxy delivery platform; Unnatural Products develops their proprietary drug discovery platform; and more.

    Mar 25, 2026

  • Verily, Samsung Collaboration, PathAI Receives FDA Approval, LinusBio Expands Test Further

    Diagnostics World | Verily Life Sciences and Samsung Electronics America enter a collaboration; PathAI announces that the U.S. Food and Drug Administration has granted Breakthrough Device Designation to PathAssist Derm; LinusBio announces that ClearStrand-ASD is now available for children up to age 10; and more.

    Mar 24, 2026